Pesquisas alternativas:
disease linked » disease like (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
linked ther » linked ter (Expandir a Pesquisa), linked mother (Expandir a Pesquisa), linked three (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa)
drug noise » drug naive (Expandir a Pesquisa), drug nurse (Expandir a Pesquisa), during noise (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
does deep » does sleep (Expandir a Pesquisa), does diet (Expandir a Pesquisa)
deep ther » deep tier (Expandir a Pesquisa), deep than (Expandir a Pesquisa), deep tcr (Expandir a Pesquisa)
disease linked » disease like (Expandir a Pesquisa)
drug disease » drug release (Expandir a Pesquisa)
linked ther » linked ter (Expandir a Pesquisa), linked mother (Expandir a Pesquisa), linked three (Expandir a Pesquisa)
drugs does » drugs do (Expandir a Pesquisa)
drug noise » drug naive (Expandir a Pesquisa), drug nurse (Expandir a Pesquisa), during noise (Expandir a Pesquisa)
level ther » level theory (Expandir a Pesquisa), level rather (Expandir a Pesquisa), levels other (Expandir a Pesquisa)
does deep » does sleep (Expandir a Pesquisa), does diet (Expandir a Pesquisa)
deep ther » deep tier (Expandir a Pesquisa), deep than (Expandir a Pesquisa), deep tcr (Expandir a Pesquisa)
1
Assuntos:
“...Adis Drug Q&A...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
“...In most cases, cytotoxic drugs do not preferentially accumulate at the tumor site, causing unwanted...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
“... disease drug trials do not account for the heterogeneity of the disease in trial design, impeding...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Cummings, Jeffrey, Aisen, Paul S., DuBois, Bruno, Frölich, Lutz, Jack, Clifford R., Jones, Roy W., Morris, John C., Raskin, Joel, Dowsett, Sherie A., Scheltens, Philip
Publicado no Alzheimers Res Ther (2016)
“... given the realities and challenges of AD drug development, with a focus on disease-modifying therapies...”Publicado no Alzheimers Res Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Canonical Transient Receptor Potential Channels and Their Link with Cardio/Cerebro-Vascular Diseases
Por Xiao, Xiong, Liu, Hui-Xia, Shen, Kuo, Cao, Wei, Li, Xiao-Qiang
Publicado no Biomol Ther (Seoul) (2017)
“.../cerebrovascular diseases, including hypertension, pulmonary arterial hypertension, cardiac hypertrophy...”Publicado no Biomol Ther (Seoul) (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Larsen, Maja Thim, Kuhlmann, Matthias, Hvam, Michael Lykke, Howard, Kenneth A.
Publicado no Mol Cell Ther (2016)
“...The effectiveness of a drug is dependent on accumulation at the site of action at therapeutic...”Publicado no Mol Cell Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Assuntos:
“...Adis Drug Q&A...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Pasma, Annelieke, Schenk, Charlotte V., Timman, Reinier, Busschbach, Jan J. V., van den Bemt, Bart J.F., Molenaar, Esmeralda, van der Laan, Willemijn H., Schrauwen, Saskia, van’t Spijker, Adriaan, Hazes, Johanna M. W.
Publicado no Arthritis Res Ther (2015)
“...INTRODUCTION: Non-adherence to disease-modifying antirheumatic drugs (DMARDs) hampers the targets...”Publicado no Arthritis Res Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“...Gerhard Levy started his investigations on the “Kinetics of Drug Action in Disease States...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Daugherty, Daniel, Goldberg, Joshua, Fischer, Wolfgang, Dargusch, Richard, Maher, Pamela, Schubert, David
Publicado no Alzheimers Res Ther (2017)
“...BACKGROUND: CAD-31 is an Alzheimer’s disease (AD) drug candidate that was selected on the basis...”Publicado no Alzheimers Res Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
Por Nota, Ingrid, Drossaert, Constance H. C., Taal, Erik, Vonkeman, Harald E., Haagsma, Cees J., van de Laar, Mart A. F. J.
Publicado no Arthritis Res Ther (2016)
“.... To facilitate shared decision-making and support patients in choosing between disease modifying anti-rheumatic...”Publicado no Arthritis Res Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
Por Vargas, D. M., De Bastiani, M. A., Zimmer, E. R., Klamt, F.
Publicado no Alzheimers Res Ther (2018)
“...BACKGROUND: Alzheimer’s disease (AD) is a multifactorial and complex neuropathology that involves...”Publicado no Alzheimers Res Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por van Vollenhoven, Ronald, Helt, Cameron, Arora, Vipin, Zhong, Jinglin, Correia, Ana Pinto, de la Torre, Inma, Muram, David
Publicado no Rheumatol Ther (2018)
“... response at the 20% improvement level (ACR20) and Clinical Disease Activity Index (CDAI) ≤ 10 at week 12...”Publicado no Rheumatol Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Schub, David, Assmann, Gunter, Sester, Urban, Sester, Martina, Schmidt, Tina
Publicado no Arthritis Res Ther (2018)
“... their levels and functionality were impacted by disease-modifying antirheumatic drugs (DMARDs). A polyclonal...”Publicado no Arthritis Res Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Kragstrup, Tue Wenzel, Greisen, Stinne Ravn, Nielsen, Morten Aagaard, Rhodes, Christopher, Stengaard-Pedersen, Kristian, Hetland, Merete Lund, Hørslev-Petersen, Kim, Junker, Peter, Østergaard, Mikkel, Hvid, Malene, Vorup-Jensen, Thomas, Robinson, William H., Sokolove, Jeremy, Deleuran, Bent
Publicado no Arthritis Res Ther (2016)
“... disease. METHODS: Plasma IL-19, IL-20, and IL-24 levels were measured in early RA patients during a treat...”Publicado no Arthritis Res Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Jin, Yinzhu, Desai, Rishi J., Liu, Jun, Choi, Nam-Kyong, Kim, Seoyoung C.
Publicado no Arthritis Res Ther (2017)
“...BACKGROUND: Biologic disease-modifying antirheumatic drugs (DMARDs) are increasingly used...”Publicado no Arthritis Res Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
Por Rad, Sima Kianpour, Arya, Aditya, Karimian, Hamed, Madhavan, Priya, Rizwan, Farzana, Koshy, Shajan, Prabhu, Girish
Publicado no Drug Des Devel Ther (2018)
“...The pathophysiological link between type 2 diabetes mellitus (T2DM) and Alzheimer’s disease (AD...”Publicado no Drug Des Devel Ther (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Yokoyama, Kaoru, Yamazaki, Kiyotaka, Katafuchi, Miiko, Ferchichi, Sameh
Publicado no Adv Ther (2016)
“...INTRODUCTION: Crohn’s disease (CD) is a chronic and progressive disease in which the long-term...”Publicado no Adv Ther (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20
Por Schiff, Michael, Takeuchi, Tsutomu, Fleischmann, Roy, Gaich, Carol L., DeLozier, Amy M., Schlichting, Douglas, Kuo, Wen-Ling, Won, Ji-Eon, Carmack, Tara, Rooney, Terence, Durez, Patrick, Shaikh, Saeed, Hidalgo, Rodolfo Pardo, van Vollenhoven, Ronald, Zerbini, Cristiano A. F.
Publicado no Arthritis Res Ther (2017)
“... rheumatoid arthritis (RA) with no or minimal prior conventional synthetic disease-modifying antirheumatic...”Publicado no Arthritis Res Ther (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo